01
Oct
2020
18:00
BST
Webinar
Impacting MR and TR Patient Outcomes with the PASCAL Repair System
-
Views:
35
-
Likes:
1
Overview
This studio-based interactive broadcast will bring together a world-leading faculty for a series of presentations, engaging discussions and a live case, led by Prof Lurz from the renowned Heart Center Leipzig, in which he will demonstrate the PASCAL repair system for the treatment of Mitral Regurgitation. Whilst the focus will be on MR treatment, our faculty will also offer expert insight to TR treatment.
Moderated by Prof Nicolas Van Mieghem, from Erasmus Medical Center, Rotterdam, this dynamic event will keep its audience central to proceedings with the chance to engage with the faculty throughout with live Q&As, and polls to share the latest audience insights to the challenges, opinions and approaches in mitral and tricuspid valve disease repair.
Pipeline products from Edwards Lifesciences will also be shown.
Faculty:
Dr Fabien Praz
Dr Sinisa Markovic
Dr Edith Lubos
Ralph von Bardeleben
Philipp Lurz
Nicolas M Van Mieghem
This webinar is supported by
Agenda
Learning Objectives
- To show latest evidence and developments on what is new in mitral and/or tricuspid valve disease repair
- To discuss the clinical evidence of PASCAL repair system in the treatment of MR and TR
- To learn from case examples how PASCAL repair system improves outcomes of patients with TR
- To enhance practical learning through a step-by-step LIVE demonstration of percutaneous mitral leaflet repair with PASCAL repair system
Faculty Biographies
Nicolas M Van Mieghem
Dr Nicolas M Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology at the Thoraxcenter, Erasmus Medical Center, as a senior staff member in February 2010.
He is involved in the percutaneous coronary interventions and structural heart program. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored approximately 130 scientific papers in peer-reviewed journals.
Dr Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and is currently Medical Director of the department of Interventional cardiology at the Thoraxcenter.